Associations between ABCG2 gene polymorphisms and isolated septal defects in a Han Chinese population

DNA and Cell Biology

Volumn 33, Issue 10, 2014, Pages 689-698

  Wang, Chuan ^a,b   Xie, Liang ^a   Li, Huaying ^a,b   Li, Yifei ^a,b   Mu, Dezhi ^a   Zhou, Rong ^a   Liu, Ruiqi ^b   Zhou, Kaiyu ^a   Hua, Yimin ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; MESSENGER RNA; ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; TUMOR PROTEIN;

ABCG2 GENE; ARTICLE; CHILD; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAN CHINESE; HEART SEPTUM DEFECT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PROTEIN EXPRESSION; ADULT; BIOSYNTHESIS; CASE CONTROL STUDY; CHINA; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GENETICS; INFANT; METABOLISM; NEWBORN; PLACENTA; PREGNANCY; PROTEIN SYNTHESIS; SINGLE NUCLEOTIDE POLYMORPHISM; UMBILICAL CORD; YOUNG ADULT;

ADULT; ATP-BINDING CASSETTE TRANSPORTERS; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CHINA; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEART SEPTAL DEFECTS; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASM PROTEINS; PLACENTA; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UMBILICAL CORD; YOUNG ADULT;

EID: 84907481009     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2014.2398     Document Type: Article

References (39)

1. Atkinson, D.E., Brice-Bennett, S., and D'Souza, SW. (2007). Antiepileptic medication during pregnancy: Does fetal genotype affect outcome? Pediatr Res 62, 120-127.
2. Bailey, L.B., and Berry, R.J. (2005). Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage. Am J Clin Nutr 81, 1213S-1217S.
3. Behravan, J., and Piquette-Miller, M. (2007). Drug transport across the placenta, role of the ABC drug efflux transporters. Expert Opin Drug Metab Toxicol 3, 819-830.
4. Ceckova, M., Libra, A., Pavek, P., Nachtigal, P., Brabec, M., Fuchs, R., et al. (2006). Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo. Clin Exp Pharmacol Physiol 33, 58-65.
5. Enokizono, J., Kusuhara, H., and Sugiyama, Y. (2007). Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens. Mol Pharmacol 72, 967-975.
6. Evseenko, D.A., Paxton, J.W., Keelan, J.A. (2006). ABC drug transporter expression and functional activity in trophoblastlike cell lines and differentiating primary trophoblast. Am J Physiol Regul Integr Comp Physiol 290, R1357-R1365.
7. Garcia-Closas, M., and Lubin, J.H. (1999). Power and sample size calculations in case-control studies of gene-environment interactions: Comments on different approaches. Am J Epidemiol 149, 689-692.
8. Gedeon, C., Anger, G., Piquette-Miller, M., and Koren, G. (2008). Breast cancer resistance protein: Mediating the transplacental transfer of glyburide across the human placenta. Placenta 29, 39-43.
9. Gilboa, S.M., Desrosiers, T.A., Lawson, C., Lupo, P.J., Riehle-Colarusso, T.J., Stewart, P.A., et al. (2012). Association between maternal occupational exposure to organic solvents and congenital heart defects, National Birth Defects Prevention Study, 1997-2002. Occup Environ Med 69, 628-635.
10. Hahnova-Cygalova, L., Ceckova, M., and Staud, F. (2011). Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): Expression and function throughout pregnancy. Drug Metab Rev 43, 53-68.
11. Hanke, W., and Jurewicz, J. (2004). The risk of adverse reproductive and developmental disorders due to occupational pesticide exposure: An overview of current epidemiological evidence. Int J Occup Med Environ Health 17, 223-243.
12. Ieiri, I. (2012). Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and breast cancer resistance protein (BCRP, ABCG2). Drug Metab Pharmacokinet 27, 85-105.
13. Ifergan, I., and Assaraf, Y.G. (2008). Molecular mechanisms of adaptation to folate deficiency. Vitam Horm 79, 99-143.
14. Iqbal, M., Audette, M.C., Petropoulos, S., Gibb, W., and Matthews, S.G. (2012). Placental drug transporters and their role in fetal protection. Placenta 33, 137-142.
15. Jenkins, K.J., Correa, A., Feinstein, J.A., Botto, L., Britt, A.E., Daniels, S.R., et al. (2007). Noninherited risk factors and congenital cardiovascular defects: Current knowledge: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics. Circulation 115, 2995-3014.
16. Jonker, J.W., Buitelaar, M., Wagenaar, E., Van Der Valk, M.A., Scheffer, G.L., Scheper, R.J., et al. (2002). The breast cancer resistance protein protects against a major chlorophyllderived dietary phototoxin and protoporphyria. Proc Natl Acad Sci U S A 99, 15649-15654.
17. Jonker, J.W., Smit, J.W., Brinkhuis, R.F., Maliepaard, M., Beijnen, J.H., Schellens, J.H., et al. (2000). Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J Natl Cancer Inst 92, 1651-1656.
18. Kishi, R., Sata, F., Yoshioka, E., Ban, S., Sasaki, S., Konishi, K., et al. (2008). Exploiting gene-environment interaction to detect adverse health effects of environmental chemicals on the next generation. Basic Clin Pharmacol Toxicol 102, 191-203.
19. Kobayashi, D., Ieiri, I., Hirota, T., Takane, H., Maegawa, S., Kigawa, J., et al. (2005). Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta. Drug Metab Dispos 33, 94-101.
20. Kolwankar, D., Glover, D.D., Ware, J.A., and Tracy, T.S. (2005). Expression and function of ABCB1 and ABCG2 in human placental tissue. Drug Metab Dispos 33, 524-529.
21. Liu, X.Q., Mai, J.Z., Gao, X.M., Wu, Y., Nie, Z.Q., Ou, Y.Q., et al. (2013). [Current prevalence rate of congenital heart disease in 12 month-old and younger infants among four regions of Guangdong province]. Zhonghua Xin Xue Guan Bing Za Zhi 41, 337-340.
22. Lupo, P.J., Symanski, E., Langlois, P.H., Lawson, C.C., Malik, S., Gilboa, S.M., et al. (2012). Maternal occupational exposure to polycyclic aromatic hydrocarbons and congenital heart defects among offspring in the national birth defects prevention study. Birth Defects Res A Clin Mol Teratol 94, 875-881.
23. Mao, Q. (2008). BCRP/ABCG2 in the placenta: Expression, function and regulation. Pharm Res 25, 1244-1255.
24. Mason, C.W., Buhimschi, I.A., Buhimschi, C.S., Dong, Y., Weiner, C.P., and Swaan, P.W. (2011). ATP-binding cassette transporter expression in human placenta as a function of pregnancy condition. Drug Metab Dispos 39, 1000-1007.
25. Myllynen, P., Immonen, E., Kummu, M., and Vahakangas, K. (2009). Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues. Expert Opin Drug Metab Toxicol 5, 1483-1499.
26. Myllynen, P., Kummu, M., Kangas, T., Ilves, M., Immonen, E., Rysa, J., et al. (2008). ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-Amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) in perfused term human placenta. Toxicol Appl Pharmacol 232, 210-217.
27. Myllynen, P., Pasanen, M., and Pelkonen, O. (2005). Human placenta: A human organ for developmental toxicology research and biomonitoring. Placenta 26, 361-371.
28. Myren, M., Mose, T., Mathiesen, L., and Knudsen, L.E. (2007). The human placenta-An alternative for studying foetal exposure. Toxicol In Vitro 21, 1332-1340.
29. Ni, Z., and Mao, Q. (2011). ATP-binding cassette efflux transporters in human placenta. Curr Pharm Biotechnol 12, 674-685.
30. Pierpont, M.E., Basson, C.T., Benson, D.W., Jr., Gelb, B.D., Giglia, T.M., Goldmuntz, E., et al. (2007). Genetic basis for congenital heart defects: Current knowledge: A scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics. Circulation 115, 3015-3038.
31. Pollex, E., Lubetsky, A., and Koren, G. (2008). The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta. Placenta 29, 743-747.
32. Prouillac, C., and Lecoeur, S. (2010). The role of the placenta in fetal exposure to xenobiotics: Importance of membrane transporters and human models for transfer studies. Drug Metab Dispos 38, 1623-1635.
33. Staud, F., Cerveny, L., and Ceckova, M. (2012). Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure. J Drug Target 20, 736-763.
34. Staud, F., Vackova, Z., Pospechova, K., Pavek, P., Ceckova, M., Libra, A., et al. (2006). Expression and transport activity of breast cancer resistance protein (Bcrp/Abcg2) in dually perfused rat placenta and HRP-1 cell line. J Pharmacol Exp Ther 319, 53-62.
35. Thulstrup, A.M., and Bonde, J.P. (2006). Maternal occupational exposure and risk of specific birth defects. Occup Med (Lond) 56, 532-543.
36. Vahakangas, K., and Myllynen, P. (2009). Drug transporters in the human blood-placental barrier. Br J Pharmacol 158, 665-678.
37. Wang, C., Xie, L., Zhou, K., Zhan, Y., Li, Y., Li, H., et al. (2013). Increased risk for congenital heart defects in children carrying the ABCB1 Gene C3435T polymorphism and maternal periconceptional toxicants exposure. PLoS One 8, e68807.
38. Weier, N., He, S.M., Li, X.T., Wang, L.L., and Zhou, S.F. (2008). Placental drug disposition and its clinical implications. Curr Drug Metab 9, 106-121.
39. Zhang, Y., Wang, H., Unadkat, J.D., and Mao, Q. (2007). Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse. Drug Metab Dispos 35, 2154-2158.